期刊文献+

同期介入治疗冠心病合并锁骨下动脉硬化闭塞症研究 被引量:1

Application of simultaneous interventional therapy in patients combined with coronary artery disease and subclavian arteriosclerosis obliterans
下载PDF
导出
摘要 目的评价同期介入治疗冠心病合并锁骨下动脉硬化闭塞症的疗效和安全性。方法于2008年1月至2012年12月,对16例冠心病合并锁骨下动脉硬化闭塞症(动脉管腔狭窄至少70%)确诊患者同期行锁骨下动脉及冠状动脉介入治疗,先行球囊血管成形术,再植入支架。在术后6个月和12个月随访时,分别进行彩色超声和血管造影检查,评估再狭窄情况和临床疗效。结果 16例患者共计38处动脉狭窄病变,均成功进行了经皮介入治疗,无严重并发症发生。术后彩色超声及血管造影检查均未见动脉管腔再狭窄。结论采用同期介入治疗的方法治疗冠心病合并锁骨下动脉硬化闭塞症,具有微创、效果好、并发症少等优点,可作为临床重要的治疗方法。 Objective To evaluate the therapeutic effects and safety of simultaneous interventional therapy in patients combined with coronary artery disease (CHD) and subclavian arteriosclerosis obliterans (SAO) .Methods From January 2008 to December 2012 ,a total of 16 patients combined with CHD and SAO (degree of stenosis at least 70% ) were enrolled and treated with simultaneous interventional therapy ,including balloon angioplasty and stent im-plantation .Color ultrasound and angiography examination were performed at 6 months and 12 months after treatment respectively to evaluate restenosis and therapeutic effects .Results Simultaneous transcatherter therapy was success-fully performed in all 16 patients ,including a total of 38 lesions ,and no serious concurrent symptoms was found . Restenosis of artery was not found by postoperative color ultrasound and angiography examination .Conclusion Sim-ultaneous transcatheter therapy might be minimally invasive ,effective and with fewer complications in the treatment of CHD combined with SAO ,which could be an important treatment method .
出处 《检验医学与临床》 CAS 2014年第17期2397-2398,2401,共3页 Laboratory Medicine and Clinic
关键词 冠心病 锁骨下动脉硬化闭塞症 介入治疗 coronary heart disease subclavian arteriosclerosis obliterans interventional therapy
  • 相关文献

参考文献11

  • 1Stone PA, Srivastiva M,Campbell J E, et al. Diagnosis and treatment of subclavian artery occlusive disease[J], Ex pert Rev Cardiovasc Ther,2010,8(9): 1275-1282.
  • 2Leenders B, den Butter G, Scheltinga MR, et al. Hand muscle atrophy and digital ischemia as an unusual presen- tation of an occluded aberrant right subclavian artery: En dovascular or open approach[J]. Int J Surg Case Rep, 2013,4(7) :565-567.
  • 3l.eung DA, Spinosa DJ, Hagspiel KD, et al. Selection of stents for treating iliac arterial occlusive disease[J]. J Vasc Interv Radiol,2013,14(2):137-152.
  • 4师天雄,缪健航,胡锡祥.下肢动脉硬化性闭塞症的介入治疗体会[J].中国普外基础与临床杂志,2010,17(7):676-678. 被引量:22
  • 5Hirseh AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease(lower extremity, renal, mesenterie, and abdominal aortic) [J]. Circulation, 2006,113 ( 11 ) : 463-654.
  • 6Bakken AM, Palchik E, Saad WE, et al. Outcomes of en- doluminal therapy for ostial disease of the major branches of the aortic arch[J]. Ann Vasc Surg, 2010,22 (3) : 388-394.
  • 7Scali ST, Chang CK, Pape SG, et al. Subclavian revascu- larization in the age of thoracic endovascular aortic repair and comparison of outcomes in patients with occlusive disease[J]. J Vasc Surg, 2013,58(4) : 901-909.
  • 8唐锋,刘昌伟.炎性反应与外周动脉血管腔内治疗术后再狭窄[J].中国微创外科杂志,2006,6(11):835-837. 被引量:2
  • 9Lotun K, Shetty R, Patel M, et al. Percutaneous left axil-lary artery approach for lmpella 2.5 liter circulatory sup- port for patients with severe aortoiliac arterial disease un- dergoing high-risk-percutaneous coronary intervention [J].J Interv Cardiol,,2012,25(2) :210-213.
  • 10Badger SA, Soong CV, Lee B, et al. Prescribing practice of general practitioners in Northern Ireland for peripheral arterial disease[J]. Angiology, 2008,59 ( 1 ) : 57-63.

二级参考文献51

  • 1李伟,张小明,张学民,沈晨阳,李清乐.弹簧支架在下肢动脉硬化性狭窄和闭塞治疗中的应用[J].中华普通外科杂志,2006,21(12):856-858. 被引量:6
  • 2苑超.下肢缺血的腔内治疗现状[J].中国医学科学院学报,2007,29(1):21-24. 被引量:11
  • 3张宪生,郭宏杰,王维亮.个体化血管重建术治疗下肢多平面动脉硬化闭塞症[J].中国修复重建外科杂志,2007,21(7):671-674. 被引量:4
  • 4Kornowski R, Hong MK, Tio FO, et al. In-stent restenosis:contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol,1998, 31:224 -230.
  • 5Schillinger M, Exner M, Mlekuseh W, et al. Restenosis after femoropopliteal PTA and elective stent implantation : predictive value of monocyte counts. J Endovasc Ther, 2003,10 (3) :557 - 565.
  • 6Welt FG, Rogers C. Inflammation and restenosis in the stent era.Arterloscler Thromb Vase Biol,2002,22( 11 ) :1769 - 1776.
  • 7Rogers C, Edelman ER, Simon DI. A mAb to the beta 2-leukocyte integrin Mac-1 (CD11b/CD18) reduces intimal thickening after angioplasty or stent implantation in rabbits. Proc Natl Acad Sci USA, 1998, 95:10134 - 10139.
  • 8Rogers C, Welt FGP, Karnovsky M J, et al. Monocyte recruitment and neointimal hyperplasia in rabbits: coupled inhibitory effects of heparin. Arterioscler Thromb Vasc Biol, 1996,16 : 1312 - 1318.
  • 9Feldman L, Aguirre L, Ziol M, et al. Interleukin-10 inhibits neointimal hyperplasia after angioplasty or stent implantation in hypercholesterolemic rabbits. Circulation,2000,101 : 908-916.
  • 10Tanguay JF, Hammoud T, Geoffroy P, et al. Chronic platelet and neutrophil adhesion: a causal role for neointimal hyperplasia in instent restenosis. J Endovasc Ther,2003,10(5 ) :968 - 977.

共引文献22

同被引文献2

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部